Higher TLR7 Gene Expression Predicts Poor Clinical Outcome in Advanced NSCLC Patients Treated with Immunotherapy

Immune checkpoint inhibitors (ICIs) have revolutionized the treatment of lung cancer. However, their clinical benefit is limited to a minority of patients. To unravel immune-related factors that are predictive of sensitivity or resistance to immunotherapy, we performed a gene expression analysis by...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Genes (Basel)
Autors principals: Baglivo, Sara, Bianconi, Fortunato, Metro, Giulio, Gili, Alessio, Tofanetti, Francesca Romana, Bellezza, Guido, Ricciuti, Biagio, Mandarano, Martina, Teti, Valeria, Siggillino, Annamaria, Reda, Maria Sole, Chiari, Rita, Pistola, Lorenza, Sidoni, Angelo, Minotti, Vincenzo, Roila, Fausto, Ludovini, Vienna
Format: Artigo
Idioma:Inglês
Publicat: MDPI 2021
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8303258/
https://ncbi.nlm.nih.gov/pubmed/34209514
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/genes12070992
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars